Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Effect of Vecam 40/300 and Vecam 20/300 Compared to Omeprazole 20 mg on Gastric pH

This study has been completed.
Sponsor:
Information provided by:
Vecta Ltd.
ClinicalTrials.gov Identifier:
NCT00818870
First received: January 6, 2009
Last updated: January 26, 2010
Last verified: January 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2009
  Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)
No publications provided by Vecta Ltd.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):